THERICON GmbH of Mannheim at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
START-UP PARK

THERICON GmbH

Cubex 41 Theodor-Kutzer-Ufer 1-3, 68167 Mannheim
Germany

This company is co-exhibitor of
MEDICA Start-up Park - Messe Düsseldorf GmbH

Hall map

MEDICA 2019 hall map (Hall 13): stand E56-07

Fairground map

MEDICA 2019 fairground map: Hall 13

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.02  Imaging supplies

Our products

Product category: Imaging supplies

Multiparametric endoscopy systems

Based on a proprietary real-time multispectral imaging technology (rMSI), Thericon is developing revolutionary endoscopy visualization systems that combine in one device the most important and promising optical imaging technologies, including virtual chromoendoscopy and fluorescence imaging. Different functional and structural images presented simultaneously side-by-side or in various overlays will help surgeons recognize different structures, such as nerves, blood vessels, and malignant tissue, and inform treatment decisions. The unprecedented wealth of information also opens up huge potential for future developments, including AI-driven diagnosis.

Our devices provide a familiar interface and require no changes to surgical procedures.
The first application is in bladder cancer surgeries (transurethral resection of bladder tumor, TURBT).

More Less

About us

Company details

IMPROVING THE PROGNOSIS OF 550,000 PATIENTS DIAGNOSED WITH BLADDER CANCER EACH YEAR BY MAKING CANCER STAND OUT
Our mission is to improve the success of surgeries by enabling surgeons better to distinguish different tissue types and identify malignant lesions. Our proprietary technology enables multiparametric endoscopy where various structural and functional images are provided simultaneously.

The first application of our real-time multispectral imaging technology is in transurethral resections of bladder tumor (TURBT), where we expect it will contribute to reducing disease recurrence and minimizing collateral tissue damage.

More Less

Company data

Foundation

2019

Area of business

Electromedical equipment / Medical Technology